6625-35-0Relevant articles and documents
Sulfoxide Reduction/C(sp3)-S Metathesis Cascade in Ionic Liquid
Liu, Chenjing,Chen, Dengfeng,Fu, Yuanyuan,Wang, Fei,Luo, Jinyue,Huang, Shenlin
supporting information, p. 5701 - 5705 (2020/07/24)
A sulfoxide reduction/C-S bond metathesis cascade between sulfoxides and alkyl bromides has been developed to access high-value sulfides without the use of any catalysts or bases. In this cascade, classical Kornblum oxidation is employed to reduce sulfoxides with alkyl bromides in ionic liquid. This protocol features high functional tolerance, mild conditions, promising scalability, and sustainable solvents.
NOVEL AMINO-PHENYL-SULFONYL-ACETATE DERIVATIVES AND USE THEREOF
-
Paragraph 0117-0119, (2017/12/27)
The present invention relates to a novel amino-phenyl-sulfonyl-acetate derivative or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating diabetes comprising the same as an active ingredient.
Potent "clicked" MMP2 inhibitors: Synthesis, molecular modeling and biological exploration
Zapico, Jose Maria,Serra, Pilar,Garcia-Sanmartin, Josune,Filipiak, Kamila,Carbajo, Rodrigo J.,Schott, Anne K.,Pineda-Lucena, Antonio,Martinez, Alfredo,Martin-Santamaria, Sonsoles,De Pascual-Teresa, Beatriz,Ramos, Ana
experimental part, p. 4587 - 4599 (2011/07/29)
A new series of MMP2 inhibitors is described, following a fragment-based drug design approach. One fragment containing an azide group and a well known hydroxamate Zinc Binding Group in a α-sulfone, α-tetrahydropyrane scaffold, has been synthesized. Water-